Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by a lack of progesterone receptor and estrogen receptor alpha expression and by no or low amplification of human epidermal growth factor receptor 2 (HER-2) [1]. Here, ERBB2 is linked to triple-negative breast carcinoma.